On September 5, 2025, the European Commission published the preliminary version of the adequacy decision recognizing Brazil as ...
read +In August and September 2025, two landmark reports were released that help to situate Brazil within the innovation landscape, both internationally and domestically. At the global level, the Global Innovation Index (GII), published...
read +On September 17, 2025, President Luiz Inácio Lula da Silva enacted Law No. 15,211, known as the Digital ECA Law, in reference to the Brazilian Statute of the Child and Adolescent, which establishes...
read +In a recent decision, the Court of Justice of Santa Catarina (TJSC), through Justice João Marcos Buch, denied an Interlocutory Appeal, in a Preliminary Injunction, filed by a company and...
read +This past Monday, the Dannemann Siemsen Institute (IDS) held another edition of Agenda IDS, this time dedicated to discussing trade secrets and unfair competition considering the experiences of the European Union and Brazil. The event featured a...
read +On August 18, 2025, the Brazilian Patent and Trademark Office (BPTO) published Consultation No. 3/2025, with the aim of gathering comments from the public on the draft Guidelines for the Examination of Patent Applications related to Artificial Intelligence (AI).
read +IDS Participates in the 45th International Congress of the Brazilian Intellectual Property Association From August 17 to 19, 2025, the Dannemann Siemsen Institute (IDS) took part in the 45th International Congress of the Brazilian Intellectual Property Association (ABPI), held in São Paulo. The event, whose central theme was “Collaboration in the Age of Intelligence”, discussed […]
read +On July 9, 2025, the Department for the Promotion of Industry and Domestic Trade, of India, and the Secretariat of Competitiveness and Regulatory Affairs, of Brazil, signed a...
read +On July 28, the Dannemann Siemsen Institute (IDS) hosted another edition of Agenda IDS, featuring an in-depth debate on the indiscriminate manufacturing and use of compounded medications involving...
read +